UNITEDHEALTH GROUP INCORPORATED (Delaware) financials
$374.94−0.76%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $285.27B | $257.14B | $242.16B | $224.87B | $200.14B | $184.01B |
| Gross profit | $133.57B | $136.09B | $129.73B | $113.32B | $98.36B | $97.75B | $85.72B | $79.47B | $70.10B | $66.97B |
| Gross margin | 29.8% | 34.0% | 34.9% | 35.0% | 34.5% | 38.0% | 35.4% | 35.3% | 35.0% | 36.4% |
| Operating income | $18.96B | $32.29B | $32.36B | $28.43B | $21.65B | $22.41B | $19.68B | $15.97B | $14.19B | $12.10B |
| Net income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B |
| Net margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.1% | 6.0% | 5.7% | 5.3% | 5.3% | 3.8% |
| Diluted EPS | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 |
| EBITDA | $23.32B | $36.39B | $36.33B | $31.84B | $24.75B | $25.30B | $22.41B | $18.40B | $16.43B | $14.16B |
| Operating cash flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.58B | $16.77B | $11.49B |
| Free cash flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.52B | $14.74B | $9.78B |
| Diluted shares | 911.0M | 929.0M | 938.0M | 950.0M | 956.0M | 961.0M | 966.0M | 983.0M | 985.0M | 968.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $78.39B | $76.90B | $62.54B | $57.62B | $46.00B | $43.47B |
| Total assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B |
| Total liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B |
| Shareholders' equity | $101.70B | $102.59B | $98.92B | $86.35B | $76.48B | $70.54B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology